412
Views
15
CrossRef citations to date
0
Altmetric
Article

ASSOCIATION OF GENETIC POLYMORPHISMS WITH HEPATOTOXICITY IN PATIENTS WITH CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOMA

, PhD, , MD, PhD, , MD, PhD, , MD, , MD, , MD, PhD, , MD, PhD, , MSc, , PhD, , PhD, , MD, PhD, , PhD & , PhD show all
Pages 344-354 | Received 21 Jul 2009, Accepted 01 Mar 2010, Published online: 29 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Hai-Rong He, Ping Liu, Gong-Hao He, Wei-Hua Dong, Mao-Yi Wang, Ya-Lin Dong & Jun Lu. (2014) Association between reduced folate carrier G80A polymorphism and methotrexate toxicity in childhood acute lymphoblastic leukemia: a meta-analysis. Leukemia & Lymphoma 55:12, pages 2793-2800.
Read now
Stéphanie Dulucq, Caroline Laverdière, Daniel Sinnett & Maja Krajinovic. (2014) Pharmacogenetic considerations for acute lymphoblastic leukemia therapies. Expert Opinion on Drug Metabolism & Toxicology 10:5, pages 699-719.
Read now
Velia D’Angelo, Maria Ramaglia, Adriana Iannotta, Matteo Francese, Elvira Pota, Maria Carmen Affinita, Giulia Pecoraro, Cristiana Indolfi, Martina Di Martino, Daniela Di Pinto, Salvatore Buffardi, Vincenzo Poggi, Paolo Indolfi & Fiorina Casale. (2013) Influence of methylenetetrahydrofolate reductase gene polymorphisms on the outcome of pediatric patients with non-Hodgkin lymphoma treated with high-dose methotrexate. Leukemia & Lymphoma 54:12, pages 2639-2644.
Read now

Articles from other publishers (10)

Tao Shen, Yingdong Song, Xiangting Wang & Haiyang Wang. (2022) Characterizing the molecular heterogeneity of clear cell renal cell carcinoma subgroups classified by miRNA expression profile. Frontiers in Molecular Biosciences 9.
Crossref
C Zhu, Y W Liu, S Z Wang, X L Li, X L Nie, X T Yu, L B Zhao & X L Wang. (2017) Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis. The Pharmacogenomics Journal 18:3, pages 450-459.
Crossref
Jawad Ahmad & Joseph A. Odin. (2017) Epidemiology and Genetic Risk Factors of Drug Hepatotoxicity. Clinics in Liver Disease 21:1, pages 55-72.
Crossref
T. Adam de Beaumais, A. Baruchel & E. Jacqz-Aigrain. (2015) Approches méthodologiques en pharmacogénétique : le modèle des leucémies aiguës lymphoblastiques de l’enfant. Revue d'Oncologie Hématologie Pédiatrique 3:4, pages 215-220.
Crossref
Sujatha Suthandiram, Gin-Gin Gan, Shamsul Mohd Zain, Ping-Chong Bee, Lay-Hoong Lian, Kian-Meng Chang, Tee-Chuan Ong & Zahurin Mohamed. (2014) Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. Pharmacogenomics 15:11, pages 1479-1494.
Crossref
Elixabet Lopez-Lopez, Angela Gutierrez-Camino, Nerea Bilbao-Aldaiturriaga, Maria Pombar-Gomez, Idoia Martin-Guerrero & Africa Garcia-Orad. (2014) Pharmacogenetics of childhood acute lymphoblastic leukemia. Pharmacogenomics 15:10, pages 1383-1398.
Crossref
Alice Matimba, Fang Li, Alina Livshits, Cher S Cartwright, Stephen Scully, Brooke L Fridley, Gregory Jenkins, Anthony Batzler, Liewei Wang, Richard Weinshilboum & Lynne Lennard. (2014) Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes. Pharmacogenomics 15:4, pages 433-447.
Crossref
E Lopez-Lopez, I Martin-Guerrero, J Ballesteros & A Garcia-Orad. (2012) A systematic review and meta-analysis of MTHFR polymorphisms in methotrexate toxicity prediction in pediatric acute lymphoblastic leukemia. The Pharmacogenomics Journal 13:6, pages 498-506.
Crossref
Elixabet Lopez–Lopez, Javier Ballesteros & Africa Garcia-Orad. (2011) MTHFR 677TT genotype and toxicity of methotrexate: controversial results. Cancer Chemotherapy and Pharmacology 68:5, pages 1369-1370.
Crossref
Lucia A. Hindorff, Elizabeth M. Gillanders & Teri A. Manolio. (2011) Genetic architecture of cancer and other complex diseases: lessons learned and future directions. Carcinogenesis 32:7, pages 945-954.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.